Biotechnology News

September 26, 2014

NEW YORK--(BUSINESS WIRE)--Recap of stories on Business Wire related to Breast Cancer Awareness Month 2014

September 26, 2014

INGELHEIM, Germany--(BUSINESS WIRE)--For media outside UK and US only Boehringer Ingelheim today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for the...

September 26, 2014

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea announces the CHMP has adopted a positive opinion recommending the granting of marketing authorization for Lymphoseek in Europe for use in breast cancer, melanoma and head and neck cancers.

September 26, 2014

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency, has adopted a positive opinion...

September 26, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ:AVEO) today announced that, as part of its plan to decrease operational expenses, the Company has entered into a termination of its lease agreement pertaining to the Company’s headquarters...

September 26, 2014

DUESSELDORF, Germany--(BUSINESS WIRE)--miacom diagnostics GmbH announces Health Canada Approval for hemoFISH assays, a platform technology to analyze positive blood cultures in 30 minutes

September 26, 2014

TAIPEI, Taiwan--(BUSINESS WIRE)--PharmaEngine, Inc. (TWO: 4162), announced today that the company has signed an Amendment to its License Agreement of MM-398 (aka PEP02, nanoliposomal irinotecan injection, nal-IRI) with Merrimack Pharmaceuticals,...

September 25, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec to Report Third Quarter 2014 Financial Results on October 22, 2014.

September 25, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX) will host a quarterly conference call to discuss its third quarter 2014 financial results on Thursday, October 16, 2014, at 7:30 a.m. Central Time. To access the call, please...

September 25, 2014

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, announced today that Jacob Chacko, M.D., Chief Financial Officer, will make a presentation at the Livingston Securities Life Science...

September 25, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Researchers at Stanford University have demonstrated the ability to predict the recovery time of patients who underwent surgical trauma. Researchers used Fluidigm’s CyTOF® Mass Cytometry Instrument....

September 25, 2014

SEATTLE--(BUSINESS WIRE)--Chris Rivera (WBBA) announced today that Steven Gillis, PhD (ARCH Venture Partners), has been confirmed as keynote speaker for the Governor’s Life Sciences Summit and Annual Meeting Friday, Oct. 24.

September 25, 2014

POMONA, Calif.--(BUSINESS WIRE)--PSC Software announces the release of a highly-configurable, modular Enterprise Quality Management System, Adaptive Compliance Engine, ACE!

September 25, 2014

WASHINGTON--(BUSINESS WIRE)--Marker Test Diagnostics, an international supplier to the drug testing industry, announced today that UR Code™, its revolutionary drug testing marker is now available in the United States. Once only available in...

September 25, 2014

LONDON & BOSTON & TOKYO--(BUSINESS WIRE)--The median price of the Top 100 drugs has skyrocketed from $1,260 in 2010 to $9,400 in 2014, representing a seven-fold increase, according to Evaluate’s new USA Sales, Volume and Pricing Analysis...

September 25, 2014

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”; OTCBB:ACTCD), a leader in the field of regenerative ophthalmology, announced today that it has completed treatment of the final patient in its U.K. based Phase 1 clinical...

September 25, 2014

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc., (NASDAQ:FCSC), an autologous cell therapy company focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs, today...

September 25, 2014

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today issued a statement regarding recent correspondence between Allergan and Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (“Valeant”) that was...

September 25, 2014

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Connie Jackson, who has served as global vice president of human resources since 2005, has been promoted to senior vice president of human resources, the company said today. As senior vice president, Jackson...

September 25, 2014

WILMINGTON, N.C. & WALTHAM, Mass.--(BUSINESS WIRE)--PPD exercised its option to acquire the remaining minority ownership interest of X-Chem, Inc. -- company to continue operations as a biotechnology company with its entire leadership and...

September 25, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, today announced its participation in three...

September 25, 2014

BOSTON--(BUSINESS WIRE)--EPIRUS Biopharmaceuticals, Inc. (EPIRUS, NASDAQ: EPRS), a Boston-based biopharmaceutical company focused on the global development and commercialization of biosimilar monoclonal antibodies, announced today that it has...

September 25, 2014

CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific and pharmaceutical companies GlaxoSmithKline and Pfizer have entered into an agreement to develop a universal next-generation sequencing (NGS) oncology test.

September 25, 2014

BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Medical is pleased to announce that Jean-Marc Creissel has been named vice president of the Urology clinical division. He has served as global leader of the business unit since 2010. As vice president,...

September 25, 2014

EDMONTON, Alberta--(BUSINESS WIRE)--The BioAlberta Board of Directors announced today that Mr. Paul Stinson has been appointed BioAlberta’s new President and CEO.

September 25, 2014

BOULDER, Colo.--(BUSINESS WIRE)--Richard Hockett, M.D. and Jasmine Gruia-Gray, Ph.D. join Biodesix. Culture of dedication to patient outcomes drives new hires.

September 25, 2014

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics to Present at the 2014 Stem Cell Meeting on the Mesa

September 25, 2014

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group (NYSE MKT: XXII) reported that the FDA has granted the Company a meeting on November 12, 2014 for the Company’s potential modified risk tobacco product code-named BRAND B (“BB-1”).

September 25, 2014

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) announced today that executive management will participate in the Leerink Partners Rare Disease Roundtable being held October 1, 2014 at the Le Parker Meridien Hotel in New York City...

September 25, 2014

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH) and LipoScience, Inc. (NASDAQ:LPDX), a provider of specialized cardiovascular diagnostic laboratory tests based on nuclear magnetic resonance (NMR...

September 25, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--Covidien plc will report fourth-quarter and fiscal 2014 results on November 5.

September 25, 2014

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, today announced that its partner China...

September 25, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on the development of novel, proprietary therapeutics based on hypoxia-inducible factor (HIF) biology and the commercialization of...

September 25, 2014

--(BUSINESS WIRE)--CKR Global, Canada’s leading risk mitigation company, combats 5 myths about Canadian companies' vulnerability to RCMP scrutiny and enforcement of the Corruption of Foreign Public Officials Act.

September 25, 2014

WITTEN, Germany--(BUSINESS WIRE)--For its financial year 2014 (ended June 30, 2014) Sangui BioTech International, Inc. reports revenues from product sales and royalties in the amount of USD133,470 USD after USD105,487 in the previous financial...

September 25, 2014

SEATTLE--(BUSINESS WIRE)--Blaze Bioscience announces initiation of Phase 1b brain cancer program for Tumor PaintTM BLZ-100 under open U.S. IND.

September 25, 2014

LONDON--(BUSINESS WIRE)--An innovative medical device designed in Australia to improve management of Parkinson’s is to be made available in services in the United Kingdom, as part of a 12-month pilot project. Lead Parkinson’s research and support...

September 24, 2014

LEWISVILLE, Texas--(BUSINESS WIRE)--As previously disclosed, Orthofix International N.V. (NASDAQ: OFIX) (the “Company”) has been working to complete the filing of restated financial statements for the fiscal years ended December 31, 2013, 2012...

September 24, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, announced today that management is scheduled to participate in a fireside chat at the Leerink Partners Rare Disease...

September 24, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck will hold its third-quarter 2014 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EDT on Monday, Oct. 27.

September 24, 2014

BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) will present at the Leerink Partners Rare Disease Roundtable in New York on Wednesday, October 1, 2014 at 2:45 p.m. ET. The presentation will be available as a live...

September 24, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Leerink Partners Rare Disease Roundtable on Wednesday,...

September 24, 2014

LOS ANGELES--(BUSINESS WIRE)--Retinoblastoma is a childhood retinal tumor usually affecting children one to two years of age. Although rare, it is the most common malignant tumor of the eye in children. Left untreated, retinoblastoma can be fatal...

September 24, 2014

MIAMI--(BUSINESS WIRE)--RADIATION SHIELD TECHNOLOGIES’ (RST) THERMALLY CONDUCTIVE DEMRON OFFERS UNIQUE PROTECTION IN THE TREATMENT AND TRANSPORTATION OF EBOLA VICTIMS.

September 24, 2014

MINNEAPOLIS--(BUSINESS WIRE)--LifeScience Alley named 10 companies to this year’s New Technology Showcase, recognizing groundbreaking advancements in healthcare technology. Mayo Clinic joins as New Technology Showcase Partner.

September 24, 2014

CHICAGO--(BUSINESS WIRE)--Three Marshall, Gerstein & Borun Partners have been selected Among the Top 250 Women in IP--a listing of the leading female intellectual property attorneys in the country.

September 24, 2014

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics partners in hereditary cancer research registry, PROMPT.

September 24, 2014

NEW YORK--(BUSINESS WIRE)--Vital Capital Invests $10M In WaterHealth’s Water Purification Business Model.

September 24, 2014

BOSTON & GENEVA--(BUSINESS WIRE)--Patient-driven eData systems innovator PHT Corp.'s LogPad System, world's most popular eDiary, chosen by Agile Therapeutics for Phase 3 clinical trial of Twirla® investigational contraceptive patch.